n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Hepatitis B Virus Infection in 1 studies
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, M | 1 |
| Ye, Y | 1 |
| Wang, F | 1 |
| Zhu, J | 1 |
| Zhao, Q | 1 |
| Zheng, Y | 1 |
| Gu, Y | 1 |
| Xie, C | 1 |
| Huang, Z | 1 |
| Tai, Q | 1 |
| Chong, Y | 1 |
| Gao, Z | 1 |
1 other study available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Hepatitis B Virus Infection
| Article | Year |
|---|---|
Liver myofibroblasts up-regulate monocyte CD163 expression via PGE2 during hepatitis B induced liver failure.
Topics: Antigens, CD; Antigens, Differentiation, Myelomonocytic; Cell Count; Cell Separation; Dinoprostone; | 2014 |